3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
4
Brain Neoplasms
4
Glioma
3
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Oligodendroglioma
1
Neuritis
1
Neoplasms
1
Neoplasm Metastasis
1
Medulloblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Familial ependymoma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
73
Radiotherapy
33
Carboplatin
21
Bevacizumab
18
Irinotecan
16
Carmustine
16
Magnetic Resonance Spectroscopy
15
Vincristine
14
Surgical Procedures, Operative
13
Filgrastim
13
Procarbazine
10
Erlotinib Hydrochloride
8
Cyclophosphamide
8
Peripheral Blood Stem Cell Transplantation
7
O(6)-benzylguanine
7
Lomustine
7
Etoposide
7
sargramostim
6
Imatinib Mesylate
6
Flucytosine
6
Cisplatin
6
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
6
temsirolimus
5
Vorinostat
5
Thiotepa
5
Radiotherapy, Intensity-Modulated
5
Radiation
5
Biopsy
5
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
5
vocimagene amiretrorepvec
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Oligodendroglioma
×
Diffusion Tensor Imaging
×
Clear all
NCT02903784
2020-09-02
BNL
University Hospital, Montpellier
Phase NA
Completed
63 enrolled